209 filings
Page 9 of 11
8-K
mzhifdh3vd qxfcp1
18 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
eciirn2 txd8opkk
5 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
shs 3dc10s
12 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
5o2v0pm50bbps
29 May 13
Regulation FD Disclosure
12:00am
8-K
us0 ttkhc059
7 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
kwkghkvjfz1akuw
29 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
s9k3yq1jz37 pert0d
8 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
epqvl5 bcg
5 Dec 12
Regulation FD Disclosure
12:00am
8-K
7ib1ge6ps9 ptw
3 Dec 12
Regulation FD Disclosure
12:00am
8-K
x7yff9fuyuih8x
20 Sep 12
Regulation FD Disclosure
12:00am
8-K
1c8uty7kjso 187
30 Aug 12
Regulation FD Disclosure
12:00am
8-K
0z4mlpe
30 Aug 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3b4 tvx1emkae3
16 Jul 12
ChromaDex® Licenses Exclusive Patent Rights for Nicotinamide Riboside (NR) Vitamin Technologies from Dartmouth College
12:00am
8-K
bja9tx0unuj d6afw
12 Jun 12
ChromaDex® Corp. Names Co-founder Frank Jaksch CEO & President
12:00am
8-K
oqtwtq v9ova
24 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
rzxhv2ud3w511
17 Feb 12
ChromaDex Announces Management Changes
12:00am
8-K
zdb p8vcr3lyow
14 Feb 12
Unregistered Sales of Equity Securities
12:00am
8-K
64a9006
13 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
n6gr6ubf
1 Feb 12
ChromaDex® to Raise $10.85M in Sale of Common Stock
12:00am
8-K
06e9r8
27 Jan 12
Regulation FD Disclosure
12:00am